Pharmacyclics LLC.
54 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD) (NCT03790332) | Pharmacyclics LLC. | 2018-11-19 |
Track Pharmacyclics LLC. automatically
Every clearance here is in the API, with alerts when new ones post.